E2022 Patch Formulation Single Dose Phase I Study

Clinical trial NCT01253434 · COMPLETED

Trial details

NCT number: NCT01253434
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Japanese Healthy Male Adult Volunteers

Start date: 2010-11-01
Primary completion: 2011-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.